Aclidinium
- Generic Name
- Aclidinium
- Brand Names
- Bretaris Genuair, Duaklir, Duaklir Genuair, Eklira Genuair, Tudorza, Tudorza Genuair, Brimica Genuair
- Drug Type
- Small Molecule
- Chemical Formula
- C26H30NO4S2
- CAS Number
- 727649-81-2
- Unique Ingredient Identifier
- K17VY42F6C
Overview
Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.
Background
Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease (COPD). It has a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012.
Indication
用于治疗慢性支气管炎或肺气肿引起的急性支气管痉挛。
Associated Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Clinical Trials
FDA Approved Products
Tudorza Pressair
Manufacturer:Covis Pharma US, Inc
Route:RESPIRATORY (INHALATION)
Strength:400 ug in 1 1
Approved: 2022/08/01
NDC:70515-002
DUAKLIR PRESSAIR
Manufacturer:AstraZeneca Pharmaceuticals LP
Route:RESPIRATORY (INHALATION)
Strength:400 ug in 1 1
Approved: 2022/01/25
NDC:0310-0900
Tudorza Pressair
Manufacturer:AstraZeneca Pharmaceuticals LP
Route:RESPIRATORY (INHALATION)
Strength:400 ug in 1 1
Approved: 2021/02/23
NDC:0310-0800
DUAKLIR PRESSAIR
Manufacturer:Covis Pharma US, Inc
Route:RESPIRATORY (INHALATION)
Strength:400 ug in 1 1
Approved: 2022/08/01
NDC:70515-001
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath